Hepatocyte‐specific suppression of Angptl4 expression was recently shown to improve obesity‐associated diabetes and mitigate atherosclerosis in mice (Singh et al., 2021). Here, ANGPTL4 is linked to obesity due to melanocortin 4 receptor deficiency.